Analyzing the Future of 23andMe: Innovation and Data Assets

This chapter examines the health and prospects of 23andMe, highlighting the company's dual focus on consumer and therapeutic services. It underscores the significance of its data assets and the imperative for ongoing innovation and financial stability in the evolving landscape of genetic health care.

Transcript

Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.

Get the app